Thus, the overall activity of the FGFR2 pathway might be a more accurate predictor of breast cancer risk than rs2981578 or rs2981582 genotype status, although it is presently unclear through which cell type and in which developmental phase of the mammary gland this activity contributes most to this risk. Here, FGFR2 is linked to breast cancer.